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TrabeculationThe Id1 and Id3 genes playmajor roles during cardiac development, despite their expression being conﬁned to
non-myocardial layers (endocardium–endothelium–epicardium). We previously described that Id1Id3
double knockout (dKO) mouse embryos die at mid-gestation from multiple cardiac defects, but early
lethality precluded the studies of the roles of Id in the postnatal heart. To elucidate postnatal roles of Id genes,
we ablated the Id3 gene and conditionally ablated the Id1 gene in the endothelium to generate conditional KO
(cKO) embryos. We observed cardiac phenotypes at birth and at 6 months of age. Half of the Id cKO mice died
at birth. Postnatal demise was associated with cardiac enlargement and defects in the ventricular septum,
trabeculation and vasculature. Surviving Id cKO mice exhibited ﬁbrotic vasculature, cardiac enlargement and
decreased cardiac function. An abnormal vascular response was also observed in the healing of excisional skin
wounds of Id cKOmice. Expression patterns of vascular, ﬁbrotic and hypertrophic markers were altered in the
Id cKO hearts, but addition of Insulin-Like Growth Factor binding protein-3 (IGFbp3) reversed gene
expression proﬁles of vascular and ﬁbrotic, but not hypertrophic markers. Thus, ablation of Id genes in the
vasculature leads to distinct postnatal cardiac phenotypes. These ﬁndings provide important insights into the
role/s of the endocardial network of the endothelial lineage in the development of cardiac disease, and
highlight IGFbp3 as a potential link between Id and its vascular effectors.gy and Molecular Medicine,
e and Dentistry of New Jersey,
Newark, NJ 07107-1709, USA.
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The Id proteins are dominant negative antagonists of basic helix-
loop-helix (bHLH) transcription factors and regulate differentiation in
multiple lineages (Ruzinova and Benezra, 2003). The Id1–4 proteins
are highly expressed during embryogenesis in partially overlapping
patterns, and play major roles during development, for example
cardiac and brain development (Fraidenraich and Benezra, 2006;
Fraidenraich et al., 2004; Jen et al., 1996, 1997; Lyden et al., 1999). In
the developing heart Id1 to Id3 are expressed exclusively in
nonmyocardial layers, for example in the epicardium, endocardium
and endothelium (Fraidenraich et al., 2004).
Although ablation of 3 copies of Id1 and Id3 (Id1−/−Id3+/− or
Id1+/−Id3−/−) genes does not produce an embryonic phenotype, fullelimination of the 4 copies of Id1 and Id3 (Id1−/−Id3−/− or dKO)
genes results in cardiac defects and mid-gestation lethality (Fraidenraich
et al., 2004; Lyden et al., 1999). The cardiac phenotype is associated with
ventricular septal (VS), trabeculation and proliferation defects that result
in a marked thinning of the myocardial wall (Chien et al., 2004;
Fraidenraich et al., 2004). The “thinmyocardial wall” phenotype is shared
by a number of mouse models that lack genes implicated in non-cell
autonomous pathway deﬁciencies (Chien and Olson, 2002; Kastner et al.,
1995; Sucov et al., 1994; Yoshida et al., 1996). Injection ofWT embryonic
stem cells (ESCs) into Id dKO blastocysts corrects the cardiac defects and
the embryonic lethality of the resultant chimeric mice with just 20–40%
chimerism (Fraidenraich et al., 2004). Gene expression proﬁles in the Id
dKO hearts are restored to WT levels in the chimeras. In the Id dKO
embryos, expressionof insulin-like growth factor1 (IGF1) and IGFbinding
protein 4 (which binds and sequesters IGF1) is down- and up-regulated
respectively (Fraidenraich et al., 2004) resulting in a compromise of
myocardial proliferation. Maternal injection of IGF1 rescues myocardial
proliferation defects and extends the viability of the dKO embryos until
birth (Fraidenraich et al., 2004; Schneider et al., 2009). The hearts of the
partially rescued pups are enlarged, and display endothelial, endocardial
and ventricular septal defects (VSDs) (Fraidenraich et al., 2004).
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the roles of Id1 and Id3 genes in the postnatal heart. We reasoned that
if we speciﬁcally ablated the Id genes in just one nonmyocardial layer,
but left intact the rest of the nonmyocardium, the embryos would
survive past mid-gestation. Because the Id genes play an important
role in angiogenesis (Lyden et al., 1999), and because the impact of
loss of Id-vasculature on the postnatal heart is not known, we ablated
Id genes in the endothelium. This paradigm allows us to: 1) study
the requirement for Id genes in the endothelium and endocardium;
2) study the role of Id genes in the postnatal heart; and 3) unmask
novel vascular-related roles for Id genes in the adult mice.
In this study, we demonstrate that ablation of Id genes in the
endocardium and endothelium circumvents embryonic lethality, but
neonates develop a late gestational cardiac phenotype associatedwith
defects in trabeculation, VS and vasculature that leads to 50%
postnatal lethality. We also show that the mice that survive develop
an adult cardiac phenotype associated with defects in the vasculature.
The study determines the postnatal requirement for Id genes in the
endocardium/endothelium, allowing a phenotypic characterization of
the cardiac defects caused by absence of Id genes in the endothelium.
Methods
Mouse colonies and genotyping
Mice with a Flox insertion in the Id1 allele (Nam and Benezra,
2009) (generously provided by Drs. Nam and Benezra) andmicewith
a null mutation in the Id1 and Id3 genes (Fraidenraich et al., 2004)
(generously provided by Dr. Benezra) were crossed to generate
Id1F/FId3−/− or Id1F/−Id3−/− compound mice (referred as Id control
mice). Tie2cre transgenic mice (Kisanuki et al., 2001) (generously
provided by Dr. Yanagisawa) were subsequently crossed with Id
control mice to generate Tie2cre+Id1F/FId3−/− and Tie2cre+Id1F/−
Id3+/− mice (referred as Id cKO or Id1/3 cKO mice). Both genotypes
displayed the same phenotype. Mst1 transgenic mice (Yamamoto
et al., 2003) were generously provided by Dr. Sadoshima. Mice were
genotyped by PCR using puRe-Taq Ready-To-Go PCR beads (GE
Healthcare) from DNA obtained from tail tips using primers for Id1
Flox, Id1 wild type, Id1mutant, Id3 wild type, Id3mutant and Tie2cre
according to published protocols (Fraidenraich et al., 2004; Kisanuki
et al., 2001; Nam and Benezra, 2009). R26LacZR26mice, B6.129S4-Gt
(ROSA)26Sortm1Sor/J, for veriﬁcation of Cre/loxP-mediated recombi-
nation were purchased from The Jackson Laboratory. All animal
experiments were approved by the Institutional Animal Care and Use
Committee (IACUC) of the University of Medicine and Dentistry of
New Jersey.
Histology, immuno-, Xgal-staining and Western blot (WB)
Whole embryos were collected at embryonic days 11.5 (E11.5),
E13.5, E15.5, E17.5 and whole hearts at postnatal days 1 (P1), P30,
P60, P90 and P180. Placentas were collected at E17.5. Tissues were
parafﬁn- or cryo-embedded and sectioned. Immunoﬂuorescence was
performed on parafﬁn sections using primary antibodies for Id1
(Biocheck), PECAM-1 (Santa Cruz), IGFbp3 (R&D) and Ki67 (abcam).
Myosin heavy Chain MF20 (Developmental Studies Hybridoma Bank)
was used to detect myogenic areas at embryonic and P1 and wheat
germ agglutinin (WGA) was used to delineate cell membranes in
adult hearts. Sections were pretreated with pressure cooker boiling
for 5 min in citrate buffer (0.01 M, pH 6.0, Polyscientiﬁc), quenched of
endogenous peroxidase in 3% H2O2, and blocked prior to primary
antibody incubation. A biotin–streptavidin ampliﬁcation procedure
(Vector Labs) and tyramide signal ampliﬁcation system (TSA) (Perkin
Elmer) were used for Id1 and PECAM-1 staining while only biotin–
streptavidin ampliﬁcation was necessary for Ki67. Nuclei were
identiﬁed with DAPI (Vector Labs). Visualization of ﬂuorescence wasperformed using a Nikon Eclipse 80i microscope with NIS Elements
Imaging Software. Nuclei positive for Ki67 were counted at 20×
magniﬁcation at E13.5, E17.5, and P1 and divided by total number of
nuclei to determine proliferation percentages. Hemotoxylin and Eosin
staining was performed for morphological analysis and visualization
of ﬁbrosis was performed using Masson Trichrome Stain Kit (Richard-
Allan Scientiﬁc). Whole mount X-gal staining was performed at E11.5
with X-gal (1 mg/ml) in PBS buffer containing 5 mM potassium
ferricyanide, 5 mM potassium ferrocyanide, and 2 mM MgCl2 over-
night at 37 °C. X-gal wash buffer contained 0.02% Nonidet P-40. After
staining embryos were cryo-embedded, sectioned and eosin counter-
stained before mounting. Adult hearts (p180) were harvested, cryo-
embedded and sectioned before X-gal staining overnight at 37 °C and
subsequent eosin counterstained.
Wound healing
Six WT and cKO (P60) mice were anesthetized by isoﬂurane
inhalation. At time=0 days, two circular 7-mm-diameter wounds
were inﬂicted using an Acupunch disposable sterile 7 mm skin biopsy
punch (Accuderm Inc) and images were recorded. Wounds were
dressed with a transparent dressing (Tegaderm; 3M) following initial
wounding and again redressed at day 3. WT and cKO mice were
sacriﬁced at day 6 and the remaining mice were sacriﬁced at day 8.
Wounds with ~2 mm surrounding skin were excised at time of
sacriﬁce and bisected to provide cross-sections through the full width
of the wounds. These samples were ﬁxed and processed for parafﬁn
embedding and sectioned from both faces of the bisected tissue for
histological analysis. H&E and immunoﬂuorescence for Id1 and
PECAM-1 were performed as described above.
Semi qRT-PCR
RNA was extracted (RNeasy, QIAGEN) and 1-μg total RNA was
reverse transcribed using Superscript III reverse transcriptase (Invi-
trogen). PCR was performed with the following primers and expected
product size: Tbp1, GTCACATCGCCAACACAATC and AGAC-
CAAAGCCTGCAAGAAA, 169 bp; Tbp4, GCAGGGATGGTATTTGCACT
and TTCAGTCCCCAACTCCAAAC, 209 bp; Ang-1, TCTGCACAGTCTC-
GAAATGG and AGGCTTGGTTTCTCGTCAGA, 204 bp; IGFBP3,
AATGCTGGGAGTGTGGAAAG and CTGTCTCCCGCTTAGACTCG, 193 bp;
G3PDH primers (Clontech) for internal control, 983 bp. To produce
bands in the log phase, PCR parameters were adjusted individually.
Annealing temperatures: 55 °C 30 s for Tbp1, Tbp4, Ang1 and 60 °C
30 s for G3PDH; reaction cycle numbers: 24 for Tbp1; 29 for Tbp4 and
Ang-1 and 22 for G3PDH.
IGFbp3 incubation
Hearts were harvested from Id cKO mice at P180. Adjacent, 1-mm-
thick transverse sections atmid-levelwereused for the experiment. One
section was used for semi qRT-PCR without incubation. Two sections
were incubated at 37 °C for 4 h under rocking conditions in DMEM+
mg/ml fatty acid-free BSA. Recombinant mouse IGFbp3 (1 μg/ml) (R&D
Systems) was added to one section. No recombinant proteinwas added
to another section (untreated control). Id cKO mice with EFb50%
were used. Experiments were performed in triplicate. For IGFbp3
antibody incubation, hearts were harvested from P180 WT mice.
Adjacent, 1-mm-thick transverse sections at mid-level were used for
the experiment. One section was used for semi qRT-PCR without
incubation. Three sectionswere incubated at 37 °C for 5 h under rocking
conditions with DMEM and fatty acid-free BSA. An antibody reactive
with IGFbp3 (80 μg/ml) (AF775, R&D Systems) was added to one
section. No antibody was added to another section (untreated control).
An unrelated antibody reactive with Fst1 (80 μg/ml) (K19, Santa Cruz)
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provided identical results. Experiments were performed in triplicate.
Myocyte cross-sectional area
Myocyte cross-sectional areawas determined on digitized images of
rhodamine-labeled wheat germ agglutinin-stained sections of parafﬁn-
embedded samples (Peter et al., 2007). Hearts from 6 WT (EFN60%)
and 6 Id cKO (EFb50%) were used in this study. The myocyte outlines
were traced and the cell areas measured with Image-Pro Plus (Media
Cybernetics, Inc, Silver Spring, MD). In cross sections of LV, the
measurable cross sections of the myocytes are found in the endocardial
one third and in epicardial one third of myocardium. At least 150
myocytes were routinely measured in each region.
Microarray analysis
One-millimeter-thick transverse sections at mid-level from 2 hearts
per group (WT, Id1 KO, Id3 KO, Id cKO, IGFbp3-treated Id cKO and
IGFbp3-untreated Id cKO)were used formicroarray analysis. In the case
of Id cKO groups, enlarged heart tissues from mice with EFb50% were
collected. Sections used for microarrays were also used for semi qRT-
PCR validation and were adjacent to those used for histology. Total RNA
from heart tissue was isolated (RNeasy, QIAGEN). Gene expression was
analyzed by the GeneChip Mouse Gene 1.0 ST Array (Affymetrix).
Microarray data were processed by the RMA (robust multi-chip
analysis) method, and expressed genes were selected by the detection
above background (DABG) method. Hierarchical clustering with
Pearson correlation was employed to cluster genes and samples using
Cluster 3.0 and Tree View. Gene Ontology (GO) analysis was carried out
by hypergeometric test. Signiﬁcantly regulated genes used in GO
analysis were those with expression change greater than 1× standard
deviation of all genes. For each GO term, its associations with up- and
down-regulated genes were examined, resulting in two p-values. The
more signiﬁcant one was used to indicate the signiﬁcance of the GO
term. To report GO terms, we removed redundant ones, which
contained more than 75% of genes associated with a GO term with
higher signiﬁcance.
Data sets have been deposited in Gene Expression Omnibus (GEO),
with accession number GSE21924.
Echocardiography
Echocardiographs were performed onWT, Id control and Id cKOmice
at stages ranging from P30 to P180 to determine left ventricular (LV)
systolic fraction. Micewere anesthetized by intraperitoneal injection 2.5%
Avertin 290 mg/kg. Transthoracic echocardiography (Sequoia C256;
Acuson, Mountain View, CA) was performed using a 13-MHz linear
ultrasound transducer. The chest was shaved. Mice were placed on a
warm saline bag in a shallow left lateral position and warm coupling gel
applied to the chest. Small-needle electrocardiographic leads were
attached to each limb. Two-dimensional images and LV M-mode tracing
(sweep speed=100–200 mm/s) were recorded from the parasternal
short-axis view at themidpapillarymuscle level.M-modemeasurements
of LV internal diameter (LVID) and wall thicknesses were made from 3
consecutive beats and averaged using the leading edge-to-leading edge
convention adopted by the American Society of Echocardiography. End-
diastolic measurements were taken at the peak of R wave of EKG. End-
systolicmeasurementsweremadeat the timeof themost anterior systolic
excursion of the posteriorwall. LV ejection fraction (EF)was calculated by
the cubed methods as follows: LVEF (%)=100*[(LVIDd)3−(LVIDs)3]/
(LVIDd)3, LV fractional shortening: (LVFS %)=100*(LVIDd−LVIDs)/
LVIDd, where d indicates diastolic and s indicates systolic. Heart
rate was determined from at least three consecutive RR intervals on the
LV M-mode tracing. Following echocardiography at P180, mice weresacriﬁced and hearts harvested for histological analyses as described
above.
Data analysis
Results are presented as mean±s.e.m. or as a range. Statistical
comparison was performed with nonparametric two-tailed unpaired
analysis of variance. A probability value of b0.05 was considered to be
statistically signiﬁcant.
Results
Id1 is compromised in the endothelial lineage of Id cKO hearts
To study a requirement for Id1 and Id3 genes in the adult heart, we
analyzed Id compound mice with a Flox insertion in the Id1 allele (Nam
andBenezra, 2009) andwith anullmutation in the Id3 gene (Id1F/FId3−/−
or Id1F/−Id3−/−, referred toas Id control)mice.We incorporatedaTie2Cre
transgene into Id control mice to generate Tie2Cre+Id1F/FId3−/− or
Tie2Cre+Id1F/−Id3−/− (referred to as Id cKO) mice. Tie2 is expressed in
endothelial cells (Kisanuki et al., 2001), which highly express Id genes
(Fraidenraich et al., 2004; Ruzinova and Benezra, 2003). The Tie2
promoter, therefore, drives expression of the Cre recombinase to the
endothelial and endothelial-derived structures.
To verify that the recombination was layer-speciﬁc, Tie2Cre+Id1F/+
mice were crossed to R26LacZR26 mice, which reveal tissues (via X-gal
staining) that undergo Cre/loxP-mediated recombination (Soriano,
1999). The reporter LacZ showed that the recombination occurred in
Tie2Cre+Id1F/+R26LacZR26 compoundmice inmost of the endocardial/
endothelial cells and their derivatives like the atrio-ventricular
endocardial cushion (AVEC) (Fig. 1A). The epicardiumandmyocardium
from atria and ventricles did not undergo recombination, and therefore
did not stain blue (Fig. 1A). Accordingly, the epicardiumwas Id1positive
(Fig. 1E, comparewithD, see B, C for landmarks). Id1wasdetected in the
epicardium of both atria and ventricles, and in a few endothelial cells of
the outer layer of the epi-myocardium (Fig. 1E). In contrast, negligible
levels of Id1were observed in endothelial cells of the innermost portion
of the endomyocardium and of the VS, as well as of the endocardium
proper (Fig. 1E). These observations suggest that Tie2Cre/LoxP-
mediated recombination is more efﬁcient in the inner myocardium,
which is inﬂuenced by the endocardium, andmay express higher levels
of Tie2 (Cre). Alternatively, a portion of the epi-endothelium may
originate from endothelial-independent structures (Tie2 negative=no
Cre expression), such as from the epicardium. Thus, Tie2Cre/loxP-
mediated recombination resulted in reduced Id1 production, especially
in the most internal portions of the heart.
Id1 persisted in a fraction of the endothelium of small capillaries
and large vessels in the heart of WT mice at postnatal day 180 (P180)
(Fig. 1F, F inset, G, J, K, L), but did not persist in the epicardium or
endocardium at P180 (Fig. 1F for epicardium, G for endocardium). In
Id cKO; R26LacZR26 compound mice, Tie2Cre/loxP-mediated recom-
bination resulted in Xgal staining of the endothelial compartment
(Fig. 1N inset), coincident with absence of Id1 staining there (Fig. 1N,
comparewith L, M). Therefore, the only Id1-expressing cells in theWT
heart are Tie2Cre+ cells, which are endothelial and endothelial-
derived cells. Absence of Id1 in the epicardium and endocardium at
P180, combined with Tie2Cre-ablation of Id1 in the endothelium
leaves the heart of an adult Id cKO with no Id1 production.
Id cKO neonates develop a cardiac phenotype
We examined the phenotypic consequences of Id loss in Id cKO
embryos. In most of the experiments (except when noted), we
generated embryos from crosses of Id cKOmales and Id control females.
The two genotypes that form the Id cKO group produced identical
phenotypes.Despite the fact that Tie2Cre/loxP-mediated recombination
Fig. 1. Id1 expression is compromised in the endothelial lineage of Id cKOmice. Speciﬁc recombination is visualized in endocardial/endothelial layers by Xgal staining (A). As a result,
Id1 is reduced in the endocardium and endothelium of Id cKO developing hearts (D–E, see B–C for landmarks). Id1 expression normally persists in the endothelium, but not in the
endocardium or epicardium ofWT adult (P180) mice (F–K), but the adult (P180) heart of Id cKOmice is devoid of Id1 (L–N). Accordingly, the heart of Id cKO LacZ reporter compound
mice displays endothelial Xgal staining (N, inset). Abbreviations: Vt: ventricle; At: atrium; AV EC: atrio-ventricular endocardial cushion, Tb: trabeculae; VS: ventricular septum; epic:
epicardium; end: endocardium; Xgal: X-galactosidase staining; MF20, CD31, SMA and WGA demarcate myocardium, endocardium/endocardium, muscle vasculature and cell
periphery respectively; blue, black, yellow and red arrowheads (A): Xgal-positive endocardial, Xgal-positive endocardial-derived (AV EC), Xgal-positive endothelial and Xgal-
negative epicardial cells respectively. Yellow and orange arrows (D and E): endocardial/endothelial- and epicardial-Id1 positive cells respectively. Yellow arrowhead (F, F inset,
G and J): Id1 positive cells. Green arrows and red arrowhead (H, H inset and I): CD31 (endothelial) and SMA (vascular smooth muscle) positive staining respectively. Note that I and J
are adjacent areas displaying expression of Id1 in a subset of the endothelial lining. Red and green arrowheads (K): co-cellular localization of Id1 (nuclear) and CD31 (cytoplasmic)
staining. Light blue arrowhead (K): a cell nucleus showing no Id1/CD31 staining. Yellow arrowheads (L–N): Id1-positive cells in small and large caliber vessels. Note that Id staining is
not apparent in N (Cre/lox recombination in the Tie2+ compartment). Magniﬁcation: A–E: 40×; F–H: 100×; I–J: 200×, K: 400×; L–N: 100×; N, inset: 200×.
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is compromised in Id cKO embryos at E13.5 and E15.5, their hearts did
not display a phenotype (n=25) (Fig. 2A–D for E13.5 and data not
shown for E15.5). At E13.5 (n=14) and E15.5 (n=11), the thickness
of the myocardial wall of the Id cKO hearts did not differ from that of
WT hearts, the trabeculation network was not compromised, the
endothelial lining was continuous and the VS complete, with no VSDs
(Fig. 2A, B). Concordant with normal size and thickness, no myocardial
proliferation defectswere apparent (n=3) (%Ki67positive cells: 46±5
and 44±5 forWT and cKO respectively) (Fig. 2C, D). These experiments
suggest that partial (Tie2Cre+Id1F/−Id3−/− or Tie2Cre+Id1F/FId3−/−)
but not complete (Id1−/−Id3−/−) absence (Fraidenraich et al., 2004) of
Id does not lead to mid-gestation demise. These experiments also
suggest that Id1 signals from the non-endocardium/endothelium (i.e.
epicardium and epicardial-derived structures) sufﬁce for maintaining
normal development of the embryonic heart. This is particularly
interesting in areas of the heart that are internal and that do not appose
the epicardium. These areas, like the VS, are devoid of short-range
Id-dependent signals, and yet, display no apparent phenotype at
mid-gestation.At E17.5, Id cKO hearts exhibited VSDs (n=15) (SFig. 1). The
endocardial lining remained unaffected however a compromise in
myocardial proliferation was observed (% Ki67 positive cells: 4.9±1.0
and 0.9±0.3 for WT and cKO respectively) (n=15, Pb0.05) (SFig.
1A–D). E17.5 embryos (n=33) were collected with no resorption
sites. No change in apoptosis was observed (n=5) (data not shown).
All the embryos showed beating hearts, including the Id cKO embryos
(n=15, expected n=17).
Because most of the Id cKO embryos survived past late gestation
(88%, 15 out of 17 expected), we studied the postnatal requirement of
Id1-endothelium in the Id cKO pups. Notably, only 46% of the P1 Id cKO
mice (56 out of 120 expected) escaped postnatal lethality. The
phenotype of P1 Id cKO pups (n=11) was more pronounced to those
of E17.5 embryos (Fig. 2E–J). The heart of the P1 Id cKO pups was
enlarged (n=11) (Fig. 2F inset, compare with E inset) and displayed
VSDs (n=11) (Fig. 2F, L, compare with E, K) associated with impaired
ventricular trabeculation (n=11) (Fig. 2H, comparewithG). Trabeculae
were surrounded by discontinuous endocardial cell lining (Fig. 2H).
The VS contained one main hollow cavity, surrounded by a thin wall of
VS myocytes. Red blood cells were observed within the VS cavity,
Fig. 2. Newborn Id cKO pups developmultiple cardiac defects. E13.5 Id cKO embryos do not
developacardiacphenotype; accordingly, cell proliferation isnot compromised(A–D, seealso
Fig. 1, B and C). However, P1 Id cKO pups display enlarged hearts, with VSDs (E, F and K–N),
dilated VS vasculature (K, L insets), trabeculation defects (G, H) and distended epicardial
vasculature (I, J). Black dotted line (A, B, E and F): VS thickness; white line (A and B):
myocardial wall thickness; green, black and orange arrows (F): VS hollow cavity, myocardial
wall interruption and red blood cells in the VS cavity respectively; yellow arrowheads (H):
interrupted endocardial lining; white arrowheads (J) endothelialized epicardial vasculature;
light blue arrowheads (L inset): dilated VS vasculature. Magniﬁcation: A–F andM, N: 40×; E
and F, insets: 10×; G and H: 200×, I and J: 400×; K and L: 100×.
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interruption of the precarious VS wall was apparent (Fig. 2F). The
intramyocardial vasculature of theVSwasdilated (Fig. 2L and L inset). Inthe VS, no difference in apoptosis was apparent (n=5) (data not
shown), and negligible proliferation was observed (n=5) (% Ki67
positive cells: 2.3±1.0 and 0.5±0.3 for WT and cKO respectively,
Pb0.05). The epicardial vasculature displayed endothelial liningbutwas
dilated (Fig. 2J, compare with I). As expected, negligible levels of Id1
were observed in the heart of the Id cKO neonates (Fig. 2N, compare
with M).
Id cKO mice develop an adult cardiac phenotype
We determined the requirement for Id genes in the adult heart of
the surviving Id cKO mice at the functional and histological levels
(n=56) (Fig. 3 and Table 1).
At P30 (n=6), P60 (n=5), P90 (n=8)andP180 (n=28) the Id cKO
mice did not display VSDs or trabeculation defects (Fig. 3 and data not
shown). The hearts of P1, P30, P60, P90 and P180 Id cKO mice were
dilated (Fig. 3, Table 1 and data not shown). The heart/body (dry)
weight ratio of the adult P180 cKOmicewas 48% higher than that ofWT
mice (n=20) (Fig. 3C, D, compare with A, and Table 1, Pb0.05). The
myocyte cross-sectional area of P180 Id cKO ([552±85]μm2, n=6)was
increased relative to WT ([314±17]μm2, n=6) (Pb0.01). The endo-
myocardium of the left ventricle (apposing the Id-negative endocardi-
um) was disorganized, displayed areas with low or no cellularity and
signs of ﬁbrosis (n=14) (Fig. 3F, H, compare with E, G). The
endocardium of the adult cKO mice was partially interrupted (n=8)
(absence of CD31 positivity) (Fig. 3L, compare with 5K), with no visible
endocardial nuclei (n=8) (Fig. 3L inset, comparewith K inset). Because
the Id genes are not produced in the P180 endocardium (Fig. 1G),
developmental ablationof Id genesmayhavehad a long-term impact on
the phenotype of the adult endocardium.
Fibrotic tissue was apparent in areas surrounding large vessels
(n=14) (Fig. 3N, compare with M), but their endothelial lining
appeared normal (n=14) (data not shown). Fibrosis was not observed
in the epimyocardium (n=14) (data not shown). This vascular-
initiated pattern of ﬁbrosis differed from that of another model in
which the defect is triggered by myocardial apoptosis (n=5) (Fig. 3O)
(Yamamoto et al., 2003). The latter is exempliﬁed by overexpression of
the mammalian sterile 20 like-kinase 1 (Mst1) gene in the cardiac
myocytes (Yamamoto et al., 2003). As opposed to the Id cKO hearts
(Fig. 3N), ﬁbrosis in Mst1 Tg hearts was evenly distributed throughout
the intercellular (interstitial) space of cardiac myocytes (n=5)
(Fig. 3O). The phenotype observed (a disorganized myocardium next
to the endocardium) resembles that of the partially rescued Id dKO
neonates with maternal injection of IGF1 (Fraidenraich et al., 2004).
Monthly echocardiographic studies revealed that the left ventricular
ejection fraction (LVEF) or fractional shortening (FS) of Id cKOmicewas
reduced (n=56) (Table 1). The onset of heart dysfunction was at P90
(n=8) (data not shown). In the most severely affected Id cKO mice,
LVEF was below 50% (Table 1) (Id cKO in Fig. 3J, EF: 21% and FS: 7.9%,
compare with WT in Fig. 3I, EF: 64.7% and FS: 29.4%). Young pups
(n=11) (P30 and P60) did not show low EF or FS readings (data not
shown). This suggests that the cardiac enlargement observed in young
pups is compensatory for an intrinsic myocardial dysfunction. No
signiﬁcant difference in heart rate was observed at any stage (Table 1
and data not shown). Control hearts fromTie2Cre+Id1F/−Id3+/−mice
or other mice with higher Id copy number than Id cKO mice did not
display enlargement, ﬁbrosis, endocardial compromise or LVEF reduc-
tion (Fig. 3B and data not shown). Thus, P180 Id cKO mice develop a
vascular-initiated cardiac phenotype.
Analysis of gene expression proﬁles
We studied themolecular consequences of conditional ablation of Id
genes in the P180 heart (Fig. 4). Gene expression proﬁles were
compared in clustering analysis. The effect of genetic modiﬁcation in
Id gene (Id1 KO, Id3 KO and Id1/3 cKO) was compared with the WT
Fig. 3. P180 Id cKOmice develop cardiac defects. Hearts from adult Tie2Cre+Id1F/FId3−/− or Tie2Cre+Id1F/−Id3−/− but not from Tie2Cre+Id1F/−Id3+/− orWTmice are dilated (A–D).
The endo-myocardium of Id cKO mice displays disorganized areas of low or no cellularity ﬁlled with ﬁbrotic tissue (E–H). The Id cKO mice have decreased cardiac function (I, J). The
endocardial lining of Id cKO mice is interrupted (K, L and K, L insets). Fibrosis is apparent in the large vessels of the heart of Id cKO but not of WT of Mst1 Tg mice (M–O). N inset,
shows enlargement in Id cKO hearts (relative to M inset). Abbreviations: end (E–H): endocardium; LV (E–H): left ventricle; sep and post (I): interventricular septal wall and
posterior wall of the left ventricle respectively. Red arrows (F, H): disorganized areas of low cellularity in the endomyocardium; yellow arrows (L): regions of endocardial
interruption, white arrows (K inset): typical elongated shape of endocardial nuclei (note CD31 staining), absent in L inset; light blue arrowheads (M–O): large vessels; yellow
arrowheads (O): ﬁbrotic myocardial interstitium. Magniﬁcation: A–D: 10×; E–H: 100×; K and L: 100×; K and L, insets: 400×; M–O: 200×; M and N, insets: 10×.
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revealed that the Id cKOheart has distinct pattern fromtheheart lacking
either Id1 or Id3 (Fig. 4A).Wenext evaluated the association of gene sets
over the regulated genes using GO database. The signiﬁcant GO terms
(biological processes and cellular component) were summarized in
heatmap with statistical scores (Fig. 4B). Id cKO showed strong
regulation in cell adhesion (GO:0007155), actin ﬁlament-based process
(GO:0030029), vasculature development (GO:0001944) and oxida-
tion–reduction (GO:0055114). Those pathways are implicated in
pathological cardiac remodeling (Lehman and Kelly, 2002; Ruwhof
and van der Laarse, 2000). Id cKO also showed strong regulation inextracellular matrix (GO:0031012) and extracellular region part
(GO:0044421). The signiﬁcant GO terms are listed in STable I.
Vascular, ﬁbrotic and hypertrophic markers are dysregulated in the adult
Id cKO hearts
Microarray analysis of the extracellular matrix revealed that over
10 collagen genes were upregulated relative to WT, including types I
(ID:12842) and III (ID:12825) (STable II). Thrombospondin1 (Thbs1,
ID:21825), a potent anti-angiogenic secreted factor (Folkman, 1995;
Good et al., 1990), which is repressed by Id1 (Volpert et al., 2002), was
Table 1
Cardiac dilation, ﬁbrosis and dysfunction in P180 Id cKO mice.
WT Id cKO
Body weight (g)⁎
Females 26.2±2.6 (n=6) 22.3±2.6 (n=30)
Males 29.3±2.2 (n=9) 24.3±2.4 (n=24)
Heart weight (mg)⁎⁎, a
Females 105±16 (n=6) 118±26 (n=9)
Males 118±23 (n=5) 140±38 (n=11)
Heart/body weight (mg/g)⁎ 3.87±0.62 (n=11) 5.75±1.10 (n=20)
Fibrosis (Masson Trichrome staining)
Epimyocardium 0 (n=5) 0 (n=14)
Endomyocardium 0 (n=5) 12 (n=14)
Left Ventricular End Diastolic
Dimension (LVEDD)⁎ (mm)
3.8±0.3 (n=14) 4.3±0.7 (n=56)
Left Ventricular End Systolic
Dimension (LVESD)⁎ (mm)
2.7±0.3 (n=14) 3.3±0.7 (n=56)
Fractional Shortening (FS)* (%) 29.4±4.6 (n=14) 23.3±7.0 (n=56)
Left Ventricular Ejection
Fraction (LVEF)* (%)
64.3±6.8 (n=14) 56.2±13.2 (n=56)
Number of mice with LVEFb50 % 0 (n=14) 11 (n=56)
Heart rate (HR)**, beats/min (bpm) 450±55 (n=14) 440±62 (n=56)
In parenthesis: number of mice.
⁎ Pb0.05.
⁎⁎ PN0.05.
a Dry weight.
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Fig. 5). Thbs4 (ID: 21828) was also upregulated (STable II and Fig. 5).
Several Thbs-carrying domain proteins, like a disintegrin-like and
metallopeptidase with thrombospondin (Adamts4, 9 and 1, IDs:
240913, 101401 and 11504 respectively) (Brocker et al., 2009; Guo et
al., 2010), were also up-regulated (STable II). Adamts proteins play
key roles in extracellular matrix remodeling, including degradation of
collagen ﬁbers (Guo et al., 2010). Angiopoietin-1 (Angpt1, ID: 11600),
a secreted factor produced by myocytes that signals to the
endocardium through the Tie2 receptor and whose absence during
development leads to trabeculation defects (Suri et al., 1996), was
down-regulated (STable II, and Fig. 5) in the Id cKO hearts. As in the
phenotype of Id dKO embryos, lack of Angpt1 causes embryonic
lethality at midgestation and a thin myocardium (Suri et al., 1996).
Thus, important paracrine signals of the cardiac vasculature are
dysregulated in the Id cKO adult hearts. In the Id dKO embryos, IGF1
(ID: 16000) and IGFbp4 (ID: 16010) were down- and up-regulated
respectively (Fraidenraich et al., 2004). However, IGF1 and IGFbp4
were unchanged in the Id cKO adult hearts. Instead, IGFbp-3, 5 and 7
(IDs: 16009, 16011 and 29817 respectively) were upregulated (STable
II, Fig. 5 and data not shown). In P180WT hearts, IGFbp3 was detected
in a few small-caliber (nonmyocardial) cells that appose larger cardiac
myocytes (Fig. 6A and C). IGFbp3 was also detected in the endothelial
lining of larger vessels (Fig. 6A inset). Concordant with upregulation
of IGFbp3 (STable II and Fig. 5), IGFbp3 was enhanced in the P180 Id
cKO hearts (Fig. 6B, B inset and D), to become detectable throughout
the extracellular interstitium (Fig. 6B and D). Therefore, IGFbp3 is
expressed primarily in the nonmyocardial compartment, including
endothelial cells, and its expression is enhanced in the P180 Id cKO
heart.
Microarray analysis of markers of hypertrophy revealed that atrial
and brain natriuretic precursor peptides (Nppa or ANF and Nppb or
BNF, IDs: 230899 and 18158)were upregulated relative toWT (STable
II, and data not shown) (Gardner, 2003). The developmental Myh7
gene (β-MHC, ID: 140781) was also upregulated while the adult
Myh6 (α-MHC, 17888)was unchanged, suggesting an isozyme shift of
MHC expression (STable II) (Rajabi et al., 2007; van Rooij et al., 2007).
As expected, Id1 and Id3 (ID: 15901 and 15903 respectively) were
both downregulated relative to WT (STable II). Loss of Id1 in the Id
cKO heart was further conﬁrmed by semi qRT-PCR and Western blot
(data not shown). Id4 (ID: 15904), which is not expressed and may
not play a role in the heart (Jen et al., 1996, 1997), was unchanged(STable II). However, Id2 (ID: 15902), whose pattern of expression
and function overlaps with those of Id1 and Id3 (Jen et al., 1996,
1997), was slightly upregulated (STable II), suggesting a modest
compensatory mechanism between members of the Id family. As
expected, hearts from Tie2Cre+Id1−/−Id3+/− and Id1F/+Id3−/−mice,
which contain higher Id levels than those from Id cKO mice, did not
reveal severe changes in gene expression proﬁles (STable II). The gene
expression studies suggest that a panel of vascular, ﬁbrotic and
hypertrophic markers is altered in the hearts of Id cKO mice.
Reversion of vascular and ﬁbrotic, but not hypertrophic markers in
IGFbp3-treated Id cKO heart explants
Because Id and IGFbp3 are expressed in the endothelial compart-
ment, Id represses IGFbp3, and the IGF axis plays a role in the rescueof Id
KO embryos, we determined if IGFbp3 plays a role on the reversion of
gene expression proﬁles in Id cKOs. To this end,we incubated transverse
sections of P180 Id cKO hearts in the presence and absence of mouse
recombinant IGFbp3. In this condition, the potential interactions
between the multiple layers (myocardium–epicardium–endocardi-
um–endothelium) remain intact. We found that IGFbp3 treatment
reversed expression of genes dysregulated in Id cKO (Fig. 4A, IGFbp3
treated vs. not treated in Id cKO). Notably, an opposite regulation was
apparent in genes that belong to the extracellular matrix and
extracellular region part (GO:0031012 and GO:0044421 respectively,
compare Id1/3 cKO with IGFbp3 treated) (Fig. 4B).
IGFbp3 treatment reversed expression proﬁles of speciﬁc members
of the vascular and ﬁbrotic pathways (STable II). The anti-angiogenic
Thbs4 and Thbs1 were down-regulated by IGFbp3 addition (STable II,
and Fig. 5). This suggests that this potent, Id-dependent, anti-angiogenic
Thbs family can be normalized by IGFbp3 administration. Conversely,
expression of the pro-angiogenic Angpt1 was up-regulated by IGFbp3
addition (STable II and Fig. 5). Thus, IGFbp3 promotes expression of pro-
angiogenic markers and represses expression of anti-angiogenic
markers in Id cKO hearts. Regarding key components of the ﬁbrotic
tissue, a direct effect on speciﬁc expression of 2 collagen genes was
observed (type I and typeXV, IDs: 12842 and 12819 respectively, STable
II anddatanot shown).Despite the fact that Thbs1/4were affected, none
of the Adamts (4, 9 and 1) proteins, which contain a Thbs domain, were
changed by IGFbp3 addition (STable II). Surprisingly, however, no direct
effect of IGFbp3 was observed on the regulation of hypertrophic
markers, like ANF, BNF or βMHC (STable II). Id2 expression was not
affected by IGFbp3 administration (STable II). Similarly, no effect on
IGFbp 3, 5 and 7 was observed. However, IGFbp4 was down-regulated
(STable II), suggesting a compensatory cross-talk among members of
the IGFbp family. We also incubated transverse sections ofWT hearts in
the presence of an antibody reactive with IGFbp3. The treatment
resulted in Thbs4/1 upregulation and Angpt1 downregulation (Fig. 5).
As expected, this outcome inWTwith IGFbp3 antibody (dysregulation)
was opposite to that in Id cKO with recombinant IGFbp3 (reversion).
The experiments suggest that addition of recombinant IGFbp3 in Id-
deﬁcient hearts is corrective, and that a block of IGFbp3 mimics the
effect produced by Id-deﬁciency.
Vascular compromise takes place outside the heart
Because the vascular-speciﬁc recombination of Id1 was not
restricted to the heart, we determined if endothelial ablation of Id1
also led to angiogenic defects outside of the heart. To this end, P60 Id
cKO (n=6) or WT (n=6) mice were subjected to excisional skin
wounding (n=12, 2 wounds per mouse), and the wound healing
response was studied over a period of 8 days (Fig. 7). Wound closure
was markedly delayed in the Id cKO relative to WT (Fig. 7A–D insets).
Accordingly, histopathological examination revealed a defective
angiogenesis (Fig. 7B, D, F, compare with A, C, E). Overall, granulation
tissue formation was less dense at the Id cKO border zone of the
Fig. 4.Microarray analysis of Id cKO hearts. (A) Comparison of gene expression proﬁles in Id KOmice andmice with IGFbp3 treatment. Columns are comparisons and rows are genes.
Comparisons are Id1 KO vs. WT, Id3 KO vs. WT, Id cKO vs. WT, and IGFbp3 treated Id cKO vs. Id cKO. The log2(Ratio) values were clustered and presented in a heatmap, according to
the color scale shown at the bottom. The heatmap contains 4378 transcripts with fold change N=1.5 in at least one comparison. Clustering was carried out by hierarchical clustering
using Pearson correlation. (B) Signiﬁcant GO terms associated with regulated genes shown in (A). Top, Biological Process (BP); Bottom, Cellular Component (CC). GO terms were
analyzed by hypergeometric test. P-values were converted to−log10(P-value) for terms more associated with upregulated genes or log10(P-value) for terms more associated with
downregulated ones , and are shown in a heatmap according to the color scale shown at the bottom. The top 20 and 10 GO terms are shown for BP and CC, respectively. Id1 KO: full
absence of Id1 in Id1−/−Id3+/−Tie2Cre+; Id3 KO: full absence of Id3 in Id1F/−Id3−/−. See Supplementary Table I for the complete list of GO terms.
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burst of small, Id-positive endothelial capillaries, accompanied by
extensive granulation, emerged from the uninjured skin towards the
injured skin at the border zone, underneath a region of new
epithelium (Fig. 7A). However, in the wounds of the Id cKO mice,
granulation was markedly less dense (Fig. 7B). Consistent with almost
complete loss of wound healing activity (Fig. 7B inset), capillary
development was sparse (Fig. 7B). By day 8, the wounds were largely
healed in WT mice (Fig. 7C inset), but the wounds in the Id cKO mice
were still unhealed (Fig. 7D inset). At the histological level, less
cellularity or hypoplasticity was apparent in the Id cKO mice (Fig. 7D,
compare with C). Strikingly, a network of large caliber and distended
(Id-negative) vessels was prevalent in the Id cKO wound (Fig. 7D, F,
H). Thus, this experiment supports the notion that the Id cKO mice
have a compromised angiogenic response to external injury.Discussion
In this study we ablated Id1 and Id3 in the endocardium and
endothelium, starting at mid-gestation development. The embryos
escaped mid-gestation lethality, but developed perinatal and adult
cardiac phenotypes. Thus, the heart of the conditional KOmice appears
to be sensitive to loss of Id genes in the vasculature.
Commonalities and differences between the neonatal and the
adult cardiac phenotypes
The cardiac phenotype, starting at late gestation, presents varying
features throughout development and into adulthood. At birth, the dual
phenotype of neonatal death and survival resembles that of IGF1 KO
mice (Liu et al., 1993). The neonatal cardiac phenotype (enlargement,
Fig. 5. Vascular markers are dysregulated. Dysregulation of vascular, ﬁbrotic and
hypertrophic markers in Id cKO hearts is validated by semi qRT-PCR analysis.
Abbreviations: Thbs: thrombospondin; Angpt: angiopoietin; rIGFbp3: recombinant
mouse IGFbp3, Ab: antibody.
Fig. 6. IGFbp3 is enhanced in Id cKO hearts. IGFbp3 protein is detected primarily in the
nonmyocardial compartment of WT, including endothelial cells (A, A inset and C). Note
enhancement of IGFbp3 protein expression in the Id cKO (B, B inset andD). Abbreviations:
WGA: wheat germ agglutinin. White arrowheads (A–D): IGFbp3-positive small caliber
nonmyocardial cells; blue arrowheads (A, C): IGFbp3-negative nonmyocardial cells;
orange arrowheads (A–D): cardiacmyocytes.Magniﬁcation: A and B: 200×; A and B insets
and C and D: 400×.
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rescued by maternal injection of recombinant IGF1 (Fraidenraich et al.,
2004). Some features of the neonatal phenotype (enlargement,
endocardial/endothelial defects) are also apparent in the adult heart,
some(VSDs and trabeculation)do not exist andothers (vascularﬁbrosis
and functional deﬁcits) emerge in the adult. It is likely that absence of
VSDs in the adult heart, rather than reﬂecting corrective activities
overtime, indicates amilder phenotype of the fraction of adultmice that
survives postnatally.
Vascular compromise outside of the heart
The vascular phenotype is not conﬁned to the heart, as recombina-
tion takes place in the endothelial network globally (Kisanuki et al.,
2001). However, not all endothelial cells and/or apposing tissues are
equally affected. For example, the Id cKO placentas are devoid of Id1, yet
they do not display an obviousmorphological phenotype. Interestingly,
a process that requires a de novo generation of vasculature or neo-
angiogenesis (i.e. healing of a skin injury) appears to be highly sensitive
to Id levels, as the appearance of the vasculature in Id cKO wounded
mice is delayed and aberrant. Interestingly, despite being two different
processes, both the heart and the healing wound lead to adjacent areas
with low cellularity. Notably, the presence of a network of distended
vessels in the latter process resembles the phenotype of the coronary
vasculature of Id cKO neonates and the brain vasculature of Id dKO
embryos, which die of brain hemorrhage (Lyden et al., 1999). Because
Tie2 is also expressed in the myeloid lineage at low levels, additional
indirect cardiac effects caused by ablation of Id1 in this compartment
cannot be formally ruled out. Although the pregnant females undergo
similar vascular processes in the reproductive system, the Id cKO
females produce normal litters when crossed with Id control males.
However, the Id cKO females have to be paired for prolonged periods of
time (in some cases for 4 months) to accomplish successful pregnancies
(unpublished data). Whether the compromised/delayed capacity of the
Id cKO females to become pregnant is attributed to neoangiogenesis
defects, it remains to be determined.
Thrombospondin-1 and -4 are altered in Id cKO mice
Feweffectors of the Idpathwayhavebeen identiﬁed thus far (Bai et al.,
2007; Ciarrocchi et al., 2007; Di et al., 2006; Fraidenraich et al., 2004; Lee
et al., 2009; Lin et al.; Lyden et al., 1999; Volpert et al., 2002). This is partly
because the Id genes and their effectors are linked via non-cell
autonomous pathways, which involve the production of secreted factors
(IGF1 for example). Thus, Id genes and their effectors are not necessarily
expressed in the same tissues, making the identiﬁcation of the latter
factors cumbersome.Oneestablishedeffector of the Idpathway is Thbs1, a
potent anti-angiogenic factor (Folkman, 1995), which is repressed by Id1
(Volpert et al., 2002). The Id-dependent regulation of Thbs1 is indirect, as
expression of Id and Thbs1 does not overlap (Volpert et al., 2002). In
addition, repression of Thbs1 by Id1 is not mediated by canonical E-box
DNA consensus binding sites in the Thbs1 promoter region (Volpert et al.,
2002), supporting the notion that the regulation is indirect. Although
Thbs1 is expressed outside of the endothelium, its ultimate function is to
inhibit angiogenesis (Folkman, 1995). Thus, Thbs1 feeds back to the
endothelium,where Id1 isnormallyexpressed. In theabsenceof Id signals,
Thbs1 is upregulated, resulting in inhibitionof angiogenesis (Volpert et al.,
2002). In addition to Thbs1, we identiﬁed another member of the Thbs
family that responds to Id: Thbs4, which is also upregulated in the Id cKO
hearts.
Angiopoietin-1 is altered in Id cKO mice
Thbs is not the sole vascular target of Id. Angpt1, an essential
regulator of vascular remodeling (Davis et al., 1996; Folkman and
D'Amore, 1996; Suri et al., 1996), is downregulated in the Id cKO hearts.
Fig. 7. Angiogenesis is compromised in Id cKO excisional skin wounds. Id cKO mice display defective angiogenesis, associated with compromised granulation tissue formation by
6 days (A and B). Accordingly, the process of wound closure is delayed (A and B insets). Distended, enlarged vasculature and negligible Id1 expression are apparent in the still
unhealed wounds of Id cKO mice by 8 days (C–H, C and D insets). White arrowheads (A and B): small capillaries; white and yellow arrowheads (C–F): small and large capillaries
respectively; white arrowheads (G–H): Id1-positive cells adjacent to E–F respectively. Dotted black circles (A–D insets): perimeter of the excisional skin wounds. Magniﬁcation: A
and B: 400×; C–H: 200×; Scale bars (A–D, insets): 5 mm.
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embryonic lethal phenotype,which is characterized bydisruption of the
trabeculation network and by a thin myocardial wall (Suri et al., 1996).
Embryos deﬁcient for Angpt1 exhibit abnormal vascular architecture
where the principal defect is a failure to recruit smooth muscle and
pericyte precursors in the heart (Suri et al., 1996). Furthermore, a point
mutation in the human Tie2 gene (the receptor of the ligand Angpt1)
may lead to aberrant Tie2 function and Angpt1 downregulation, and
may play a role in the etiology of spontaneous venous malformations
(Vikkula et al., 1996). Notably, the vasculature of the Tie2 mutant
patients is distended (as in the case of the vasculature of the skin-wounded Id cKO mice) due to a reduction of surrounding smooth
muscle vascular cells (Vikkula et al., 1996). However, despite a striking
similarity of roles of the Angpt1 and Id pathways, no genetic link
between these two genes has been previously reported.
IGFbp3 corrects gene expression proﬁles
Although expression of Thbs1 is regulated by serum, and there are
serum response elements in the promoter region of Thbs1 (Framson
and Bornstein, 1993), the non-cell autonomous link between Id and
Thbs is not fully delineated. Here we identiﬁed IGFbp3, a downstream
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interaction (Cubbage et al., 1990; Jogie-Brahim et al., 2009). IGFbp3 is
a circulating factor (Jogie-Brahim et al., 2009) present in failing hearts
(Pucci et al., 2009). IGFbp3 is detected in the nonmyocardial
compartment, including the endothelium, and found to spread
throughout the extracellular region of the myocardium in the Id
cKO. Transgenic overexpression of IGFbp3 causes cardiomegaly
(Murphy et al., 1995) and external administration of recombinant
IGFbp3 (or a blocking IGFbp3 antibody) results in Thbs normalization
(or dysregulation). Interestingly, IGFbp3 targets other families of
angiogenic factors, as Angpt1 levels can also be reversed (or
dysregulated) by IGFbp3 protein (or IGFbp3 antibody) treatment.
Thus, IGFbp3 overproduction in the Id cKO hearts may be cardiopro-
tective, as it may ameliorate the phenotype of the Id cKO hearts by
reversing gene expression proﬁles of Id-dependent, vascular genes.
Importantly, external administration of IGFbp3 may aid in the rescue
of the Id cKO cardiac phenotype.
In the Id cKOmice, it is not clear if the deposition of collagen ﬁbers is
secondary to the appearance of low cellularity regions. Our data suggest
however, that IGFbp3 protein has a direct effect on the expression
(down-regulation) of speciﬁcmembers of the collagen family.Members
of a family with collagen-degrading activity (Adamts) (Brocker et al.,
2009; Guo et al., 2010) are also upregulated in the Id cKO hearts. These
proteins bear Thbs motifs. However, IGFbp3 administration does not
signiﬁcantly change expression of Adamts. This observation reinforces
the notion that the potential beneﬁcial effect of IGFbp3 on reducing the
formation of ﬁbrotic tissue may come from inhibition of expression
rather than activation of degradation of collagen.
It is possible that Id1 represses IGFbp3 in the endothelium, as both
proteins are detected there. However, we do not know if Id1 and
IGFbp3 are expressed in the same subset of the endothelium.Whether
the endothelial regulation is direct or indirect, it remains to be
determined. Because IGFbp3 is enhanced in the Id cKO and spreads
throughout the myocardial interstitium, we cannot rule out that
IGFbp3 is also produced by other cell types, like cardiac ﬁbroblasts or
myocytes. Future studies will help determine if there is a paracrine
mechanism of Id1/IGFbp3 regulation.
IGFbp3 action: IGF1-dependent or IGF1-independent?
The fact that IGF1 and IGFbp3 play different roles in the Id deﬁcient
heart at different stages raises the question of whether the role of
IGFbp3 in adult heart disease is dependent or independent of IGF1
signaling. In other words, does IGFbp3 act via a canonical mode of
action, by binding and inhibiting the function of IGF1? (Granata et al.,
2007; Jogie-Brahim et al., 2009; Rajah et al., 1997). Our results suggest
that the direct effect of IGFbp3 on angiogenic and collagen gene
expression proﬁles in the Id cKO heart explants does not appear to
implicate IGF1. In addition, IGF1 (embryonic) and IGFbp3 (adult)
appear to have different targets. While IGFbp3 targets the vasculature
and ﬁbrotic tissue, IGF1 targets the myocardium (IGF1 corrects
proliferation deﬁcits of the myocardium but fails to correct vascular
and structural defects in IGF1-treated Id dKO embryos). Nevertheless,
we cannot discount a potential canonical effect of IGFbp3 in processes
that do not implicate reversion of gene expression proﬁles.
Is the IGF axis a non-cell autonomous link between Id and its effectors?
The perinatal and the adult phenotypes are not similar. The
common denominator is the defect in the endocardium/endothelium,
which is the main source of Id. IGF1 is reduced in Id dKO embryos but
unchanged in the adult Id cKO heart. IGFbp4 is enhanced in Id dKO
embryos but unchanged in the adult Id cKO heart. Conversely, IGFbp3
is unchanged in the postnatal heart, but enhanced in the adult Id cKO
heart. Whether loss of endocardial/endothelial-Id impacts on stage-
speciﬁc non-cell autonomous links (members of the IGF axis), whichin turn impact on different effectors, it remains to be determined.
Future experiments involving administration or transgenic over-
expression of IGF members will help elucidate their roles as potential
non-cell autonomous links in the Id pathway.
Conclusion
The results obtained in this study suggest that loss of developmental
Id in the endothelium of Id cKO mice results in postnatal vascular-
associated cardiac phenotypes. The heart becomes sensitive to the
vascular compromise at two postnatal stages, one at late development
and another in the adult. The latter defects are accompanied by
dysregulation of vascular, ﬁbrotic and hypertrophic pathways, along
with the production of IGFbp3. Excess of IGFbp3 in turn reverses
vascular and ﬁbrotic, but not hypertrophic gene expression proﬁles in
heart explants. Blocking IGFbp3 promotes dysregulation, thus mimick-
ing the effect produced by Id loss. Recently, a polymorphism in the Id3
gene has been associated with vascular intima-media thickness in
humans (Doran et al.). Therefore, the elucidation of the roles of Id genes
in the developmental vasculature and their consequences in the
postnatal heart will have tremendous implications for human congen-
ital and adult ﬁbrotic cardiomyopathy.
Supplementarymaterials related to this article can be found online
at doi:10.1016/j.ydbio.2010.10.004.
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